A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...
The regulatory greenlight was backed by two Phase III trials that showed normalized growth hormone levels in patients with ...
The U.S. Food and Drug Administration approved Crinetics Pharmaceuticals' drug to treat a rare hormonal disorder on Thursday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback